ARROWHEAD PHARMACEUTICALS, INC. (ARWR) › RevenueARROWHEAD PHARMACEUTICALS, INC. (ARWR) — RevenueAnnual figures by fiscal year, from SEC filings.2017: $31.41M2018: $16.14M2019: $168.80M2020: $87.99M2021: $138.29M2022: $243.23M2023: $240.74M2024: $3.55M2025: $829.45M$829.45M2017Revenue (USD)2025Fiscal YearRevenueChange YoY2025$829.45M+23258.2%2024$3.55M-98.5%2023$240.74M-1.0%2022$243.23M+75.9%2021$138.29M+57.2%2020$87.99M-47.9%2019$168.80M+945.7%2018$16.14M-48.6%2017$31.41M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share